{"organizations": [], "uuid": "60104f643d5bc17c5dd8ded860f8872b95ab564c", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "", "site_section": "http://odreport.com/feed/", "section_title": "The Overdose Report", "url": "https://www.reuters.com/article/regeneron-pharms-sanofi-cholesterol/update-1-regeneron-sanofi-heart-drug-succeeds-in-major-trial-will-insurers-pay-idUSL1N1QS042&", "country": "US", "domain_rank": 408, "title": "UPDATE 1-Regeneron/Sanofi heart drug succeeds in major trial; Will insurers pay?", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "blogs", "published": "2018-03-10T18:30:00.000+02:00", "replies_count": 0, "uuid": "60104f643d5bc17c5dd8ded860f8872b95ab564c"}, "author": "", "url": "https://www.reuters.com/article/regeneron-pharms-sanofi-cholesterol/update-1-regeneron-sanofi-heart-drug-succeeds-in-major-trial-will-insurers-pay-idUSL1N1QS042&", "ord_in_thread": 0, "title": "UPDATE 1-Regeneron/Sanofi heart drug succeeds in major trial; Will insurers pay?", "locations": [], "entities": {"persons": [], "locations": [], "organizations": []}, "highlightText": "", "language": "english", "persons": [], "text": " ", "external_links": [], "published": "2018-03-10T18:30:00.000+02:00", "crawled": "2018-03-10T20:50:20.012+02:00", "highlightTitle": ""}